GRAPE-GDM Prospective Comperative Trial - Grape Juice as a Replacement Drink for Gestational Diabetes Screening
GRAPE-GDM
1 other identifier
interventional
150
1 country
1
Brief Summary
Study Type: Observational, prospective, multicenter comparative study Primary Purpose: The goal of this study is to evaluate whether grape juice can serve as an effective alternative to the standard 50g glucola drink for gestational diabetes screening in pregnant individuals at 24-28 weeks of gestation. Main Questions: Can an alternative glucose-loading drink (grape juice) provide comparable blood glucose measurements to the standard GCT? Does grape juice improve patient satisfaction and compliance with gestational diabetes screening? Comparison Group: Researchers will compare the standard GCT (50g glucola drink) with the alternative GCT (500 ml grape juice containing 50g sugar). Each participant will undergo both tests, serving as her own control, to assess differences in glucose measurements and patient preferences. Participant Tasks: Participants will: \- Undergo two glucose challenge tests (GCT): Standard GCT (50g glucola) at their health maintenance organization (HMO) or hospital. Alternative GCT (500 ml grape juice) during a scheduled visit or hospitalization.
- Have blood drawn one hour after each test for glucose measurement.
- Complete a questionnaire assessing satisfaction and preference between the two methods.
- Provide follow-up information if they require additional testing (e.g., 100g OGTT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 19, 2025
CompletedFirst Submitted
Initial submission to the registry
May 7, 2025
CompletedFirst Posted
Study publicly available on registry
January 7, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 28, 2028
January 7, 2026
March 1, 2025
2 years
May 7, 2025
January 1, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Blood glucose concentration after test beverage
Venous plasma glucose ( measured at 60 minutes after each beverage
one hour from injestion of the drink
Secondary Outcomes (3)
Participant satisfaction with glucose drink
One hour after ingestion of the glucose drink.
Participant preference for glucose challenge test drink
One hour after ingestion of the glucose drink.
Adverse events following glucose drink ingestion
One hour after ingestion of the glucose drink.
Other Outcomes (3)
Gestational age at birth
At delivery
Neonatal birth weight
At birth
Mode of delivery
At delivery
Study Arms (1)
grape juice
EXPERIMENTALParticipants: Each participant will undergo both the standard GCT and an alternative GCT using 500 ml of grape juice (containing 50g of sugar). Control Group: Each participant serves as her own control by completing both tests in a randomized order.
Interventions
This study investigates a non-carbonated, natural beverage (grape juice) as an alternative glucose-loading method for gestational diabetes screening. Unlike other studies that have explored alternative carbohydrate sources such as jelly beans or gummy candies-which require chewing and may impact dental health-our study focuses on a readily available liquid alternative that closely mimics the glucose absorption kinetics of the standard 50g glucola drink.
Eligibility Criteria
You may qualify if:
- Pregnant individuals scheduled for routine GCT at 24-28 weeks. Well-dated pregnancy (confirmed first-trimester ultrasound). Willingness to comply with study protocol.
You may not qualify if:
- High-risk individuals requiring direct 100g OGTT (e.g., prior GDM, BMI \>40, PCOS).
- Intolerance to the alternative drink. Gastrointestinal conditions affecting glucose absorption such as active bowel disiease.
- Recent corticosteroid administration for fetal lung maturity after standard GCT.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bnai Zion Medical Center
Haifa, Israel
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 7, 2025
First Posted
January 7, 2026
Study Start
February 19, 2025
Primary Completion (Estimated)
February 28, 2027
Study Completion (Estimated)
February 28, 2028
Last Updated
January 7, 2026
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share
De identified individual participant data collected in this study will not be shared outside the study team.